Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-11-000033
Filing Date
2011-01-18
Accepted
2011-01-18 14:59:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 PHARMATHENE, INC. p11-0095sc13ga.htm SC 13G/A 82517
  Complete submission text file 0000902664-11-000033.txt   84481
Mailing Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401
Business Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401 410 269 2600
PHARMATHENE, INC (Subject) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-80900 | Film No.: 11533007
SIC: 2834 Pharmaceutical Preparations

Mailing Address 120 BROADWAY, SUITE 1019 NEW YORK NY 10271
Business Address 120 BROADWAY, SUITE 1019 NEW YORK NY 10271 212-608-3300
Empery Asset Management, LP (Filed by) CIK: 0001469336 (see all company filings)

EIN.: 262107121 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A